Washington, September 20
Scientists in the US have developed a new genomic test that can predict a patient’s risk of developing severe Covid, an advance that could help doctors quickly begin tailored treatment.
The test proved over 90 per cent accurate at predicting patient outcomes for Covid among over two dozen patients in intensive care and 100 patients from publicly available data, the researchers said.